QUEST DIAGNOSTICS INC shareholders Q3 2023

QUEST DIAGNOSTICS INC's ticker is DGX and the CUSIP is 74834L100. A total of 784 filers reported holding QUEST DIAGNOSTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.

QUEST DIAGNOSTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Kestra Advisory Services, LLC 5,534$674,3730.01%
AXXCESS WEALTH MANAGEMENT, LLC 1,668$203,2900.01%
B. Riley Wealth Advisors, Inc. 2,022$246,4050.01%
EP Wealth Advisors, LLC 3,487$424,8670.01%
RAYMOND JAMES TRUST N.A. 1,698$206,9160.01%
PRIVATE TRUST CO NA 382$46,5510.01%
Cambridge Investment Research Advisors, Inc. 11,181$1,3620.01%
Boston Common Asset Management, LLC 1,995$2430.01%
Orion Capital Management LLC 70$8,5300.01%
Walleye Capital LLC 20,500$2,498,1300.01%
THRIVENT FINANCIAL FOR LUTHERANS 20,310$2,4750.01%
Parkside Financial Bank & Trust 199$24,2510.01%
NATIONAL BANK OF CANADA /FI/ 31,336$3,788,7680.01%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 16,620$2,025,3130.01%
SCHARF INVESTMENTS, LLC 1,758$214,2300.01%
Steward Partners Investment Advisory, LLC 3,108$378,7850.01%
Vident Advisory, LLC 1,721$209,7320.01%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 241,900$29,477,9340.01%
Horizon Investments, LLC 1,610$195,0520.01%
TD ASSET MANAGEMENT INC 37,668$4,590,2220.01%
About QUEST DIAGNOSTICS INC

Quest Diagnostics Inc. is a leading provider of diagnostic information services. The company offers a wide range of services, including clinical laboratory testing, diagnostic imaging, and information technology solutions. Quest Diagnostics operates in the United States, serving patients and healthcare providers across the country.

The company has a strong reputation for quality and accuracy, with a focus on providing timely and reliable results. Quest Diagnostics has a team of highly trained professionals who use the latest technology and techniques to deliver accurate and actionable information to patients and healthcare providers.

Quest Diagnostics has a strong financial position, with a solid balance sheet and a history of consistent growth. The company has a market capitalization of over $15 billion and generates annual revenues of more than $7 billion.

Quest Diagnostics is led by a team of experienced executives, including CEO Steve Rusckowski and CFO Mark Guinan. The company has a strong commitment to innovation and is constantly exploring new ways to improve its services and expand its offerings.

Overall, Quest Diagnostics is a well-respected and successful company that is poised for continued growth and success in the years ahead. With a focus on quality, accuracy, and innovation, Quest Diagnostics is a leader in the diagnostic information services industry and a valuable partner for patients and healthcare providers alike.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists QUEST DIAGNOSTICS INC's shareholders in Q3 2023. To view QUEST DIAGNOSTICS INC's shareholder history, click here.